Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Gland Pharma Limited Call Transcript 2026

Jan 28, 2026

59319_rns_2026-01-28_24a2d0f2-5408-45e9-99f6-b0eccde73600.pdf

Call Transcript

Open in viewer

Opens in your device viewer

==> picture [59 x 48] intentionally omitted <==

==> picture [298 x 20] intentionally omitted <==

January 28, 2026

BSE Limited Corporate Relationship Department Phiroze Jeejeebhoy Towers 25[th] floor, Dalal Street Mumbai - 400 001 Scrip Code: 543245

National Stock Exchange of India Limited Listing Department Exchange Plaza, 5th floor Plot no. C-1, Block G, Bandra Kurla Complex Bandra (East), Mumbai - 400 051 Symbol: GLAND (ISIN: INE068V01023)

Dear Sir/Madam,

Sub: Earnings Call Recording

Pursuant to Regulations 30 and 46 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and in continuation to our earlier disclosures dated January 09, 2026; please note that the Earnings Call for the quarter and nine months ended December 31, 2025 was held on January 28, 2026 at 18:30 Hrs. (IST) and the audio recording of the call has been uploaded on our website.

The weblink to access the same is https://glandpharma.com/images/Q3_FY26.mp3

This is for your information and records.

Yours truly, For Gland Pharma Limited

Digitally signed by Pallerlamudi Pallerlamudi Sampath KumarDN: cn=Pallerlamudi Sampath Kumar, c=IN, o=Personal, Sampath Kumar [email protected] Date: 2026.01.28 21:07:48 +05'30' Sampath Kumar Pallerlamudi Company Secretary & Compliance Officer

==> picture [596 x 78] intentionally omitted <==